Treatment of excessive menstrual bleeding associated with uterine fibroids
AssigneePregLem SA
InventorsErnest Loumaye, Elke Bestel, Ian Osterloh
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to benign gynecological diseases and in particular to a method and compositions for reducing heavy menstruation associated with said gynecological diseases following treatment with vascular occlusion methods or thermal related treatment methods.
Claims20
A method for normalizing excessive menstrual bleeding in a human subject comprising administering to the subject in need thereof, a therapeutically effective dose of a progesterone receptor modulator selected from the group consisting of CDB 2914, mifepristone, asoprisnil, onapristone, org33628, tanaproget, and tanaproget-combo, or a metabolite of CDB 2914 selected from the group consisting of CDB-3877, CDB-3963, CDB-3236, and CDB-4183,
- wherein the subject is suffering from a benign gynecological disease selected from the group consisting of uterine fibroids, adenomyosis, or a combination thereof, and
- wherein the subject is treated with a vascular occlusion method or a thermal related treatment.
Dependencies are inferred from the claim text.